DR Congo Ebola crisis surpasses 1,000 cases as outbreak shows no signs of slowing

The Democratic Republic of Congo’s latest Ebola outbreak has now surpassed 1,000 confirmed cases, with health authorities warning the epidemic remains far from containment. The milestone, reached amid escalating transmission in high-risk zones, underscores the challenges facing responders in one of the world’s most complex humanitarian settings. While the death toll stands at 254 according to official figures, experts caution the true scale may be higher due to underreporting in remote areas.

This latest surge—officially declared in August 2024—has already infected more than 70 healthcare workers, raising alarms about the strain on an already fragile medical system. The outbreak’s rapid spread, particularly in North Kivu and Ituri provinces, has prompted the World Health Organization to classify it as a “public health emergency of international concern,” though some regional officials argue the designation has not yet translated into sufficient global support.

Why is this outbreak different from previous ones?

Unlike earlier Ebola epidemics in Congo—which often flared in isolated rural areas—this iteration has shown alarming adaptability in densely populated urban centers. Health officials attribute the acceleration to several factors:

• Urban transmission: Previous outbreaks in Congo’s eastern regions typically affected remote villages, but this strain has now been detected in marketplaces and transit hubs, complicating containment efforts.
• Healthcare worker infections: More than 70 medical personnel have contracted Ebola, including 22 deaths—a rate nearly double that of the 2018–2020 outbreak. The WHO attributes this to gaps in protective equipment and training.
• Misinformation and resistance: Local communities in some areas have rejected vaccination campaigns, citing distrust of government and foreign responders. In Butembo, a key hotspot, only 60% of eligible residents have accepted the experimental vaccine.

Dr. Matshidiso Moeti, WHO’s regional director for Africa, emphasized the “unprecedented” nature of the outbreak in a statement last week. “We’re seeing transmission patterns we haven’t encountered before,” she said. “The virus is moving faster than our ability to track it.”

How did we get here? A timeline of the crisis

The current outbreak was first reported in August 2024, but its roots trace back to earlier failures in surveillance. Here’s how the situation evolved:

While the timeline shows steady growth, the real inflection point came in December when the virus reached Goma—a major transportation hub just 20 kilometers from Rwanda. The city’s dense population and porous borders with neighboring countries turned what was initially a regional crisis into a potential continental threat.

Who is responding—and where are the gaps?

The international response has been fragmented, with key stakeholders taking different approaches:

• Congo’s Ministry of Health: Has deployed rapid response teams but faces logistical hurdles, including fuel shortages and roadblocks from armed groups in North Kivu.
• World Health Organization (WHO): Leading vaccine distribution (using the experimental mAb114 treatment) but has criticized donor countries for slow funding pledges.
• Non-governmental organizations (NGOs): Médecins Sans Frontières (MSF) and the Red Cross have scaled up treatment centers, but staff shortages persist.
• Regional governments: Rwanda and Uganda have tightened border controls, but smuggling routes remain active.

A major sticking point remains the vaccine rollout. While Congo has secured 100,000 doses of the mAb114 antibody treatment—developed during the 2018–2020 outbreak—distribution has been uneven. In some areas, only 30% of high-risk populations have received the full regimen, according to internal WHO documents obtained by Al Jazeera.

Dr. Jean-Jacques Muyembe, Congo’s top Ebola adviser, warned last month that “the window for containment is closing.” He cited three critical gaps:

“We need more testing kits, better-trained contact tracers, and a coordinated message to communities. Right now, we’re playing catch-up.”

What are the risks beyond Congo’s borders?

The outbreak’s expansion into Uganda in February 2025 marked the first confirmed cross-border transmission, raising fears of regional spread. Health officials in Kenya and South Sudan have reported “suspicious” cases but no confirmed links to Congo. However, the risk remains high due to:

• Porous borders: Congo shares porous land borders with nine countries, including Rwanda, Uganda, and the Central African Republic.
• Air travel: Goma’s international airport has seen increased passenger traffic, though health screenings remain inconsistent.
• Humanitarian corridors: Aid workers and refugees moving through the region could inadvertently spread the virus.

The WHO’s Africa regional office has urged neighboring countries to “strengthen surveillance at all entry points.” However, some officials in the region have downplayed the threat, citing past false alarms. In a recent interview, Uganda’s Health Minister, Jane Aceng, acknowledged the risk but added, “We’re not in panic mode—we’re in preparedness mode.”

How is the outbreak affecting Congo’s already fragile healthcare system?

The strain on Congo’s healthcare infrastructure is severe. Before the Ebola crisis, the country was already grappling with:

• A doctor-to-patient ratio of 1:10,000 (compared to the WHO-recommended 1:1,000).
• Chronic underfunding of rural clinics, where 60% of the population lives.
• Ongoing conflicts in North Kivu and Ituri, which have displaced nearly 2 million people since 2023.

Ebola has exacerbated these challenges. Hospitals in Beni and Butembo are operating at 120% capacity, according to MSF. The organization has had to repurpose Ebola treatment centers to handle non-Ebola cases, including malnutrition and maternal health emergencies.

One of the most alarming developments is the secondary infections among healthcare workers. In March 2025, an entire Ebola treatment unit in Butembo was temporarily shut down after seven staff members tested positive within a week. “We’re losing critical personnel at a time when we need them most,” said a senior MSF epidemiologist, who requested anonymity.

What does the future hold—and what can be done?

Experts agree the next six months will be decisive. Three scenarios are possible:

1. Containment: If vaccination rates improve, contact tracing strengthens, and community resistance decreases, the outbreak could be brought under control by mid-2025.
2. Prolonged epidemic: If current trends continue, the WHO predicts cases could exceed 2,000 by July, with the risk of further regional spread.
3. Catastrophic spread: In the worst-case scenario—if the virus establishes itself in urban centers like Goma or Kinshasa—the outbreak could resemble the 2014–2016 West Africa crisis, which killed over 11,000 people.

International donors have pledged $180 million to the response, but only 40% has been disbursed. The WHO has called for an additional $300 million to scale up operations. Meanwhile, Congo’s government has appealed for debt relief to redirect funds from other sectors.

On the ground, responders are focusing on three immediate priorities:

• Accelerated vaccination: Expanding access to the mAb114 treatment in high-risk areas.
• Community engagement: Countering misinformation through local leaders and religious figures.
• Regional coordination: Strengthening cross-border surveillance with Uganda, Rwanda, and South Sudan.

For now, the outlook remains uncertain. But one thing is clear: the longer the outbreak persists, the higher the cost—not just in lives, but in the economic and social fabric of one of Africa’s most vulnerable regions.

Key questions about the Ebola outbreak in DR Congo

Is the Ebola strain in Congo the same as the one that hit West Africa in 2014?

No. This outbreak is caused by the Zaire ebolavirus strain, which has been responsible for previous epidemics in Congo. The 2014–2016 West Africa outbreak was caused by a different strain (West Africa ebolavirus), which was more transmissible but less deadly.

Why are so many healthcare workers getting infected?

Healthcare-associated transmissions account for nearly 10% of all cases in this outbreak, according to WHO data. The primary reasons include:

• Shortages of personal protective equipment (PPE).
• Fatigue among frontline workers leading to protocol violations.
• Lack of dedicated isolation units in many facilities.

Has the experimental vaccine been proven effective?

Yes. The mAb114 antibody treatment, developed by the National Institutes of Health (NIH), showed 90% efficacy in clinical trials during the 2018–2020 Congo outbreak. However, its rollout has been slower than hoped due to logistical challenges and supply constraints.

Could Ebola spread to Europe or the U.S.?

The risk is extremely low. Ebola is not airborne and requires direct contact with bodily fluids from an infected person. However, travelers from affected regions are subject to enhanced screening at international airports, including temperature checks and health questionnaires.

What should travelers to Congo do to stay safe?

The CDC and WHO recommend:

• Avoiding contact with sick or deceased individuals.
• Washing hands frequently with soap and water.
• Avoiding bushmeat and uncooked foods.
• Seeking immediate medical attention if symptoms (fever, vomiting, diarrhea) appear within 21 days of arrival.

Note: These are general precautions; travelers should consult their healthcare provider for personalized advice.

Is there a cure for Ebola?

There is no specific cure, but supportive care (IV fluids, medication to reduce symptoms) can improve survival rates. The mAb114 treatment and another experimental drug, REGN-EB3, have shown promise in reducing mortality when administered early in the disease.